Trial
NCT04475601
Enzalutamide Treatment in COVID-19
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Andreas Josefsson
Collaborators
Umeå University; Sahlgrenska University Hospital; University Hospital, Umeå; Uppsala University Hospital; Skane University Hospital; Jonkoping County Hospital; Sundsvall Hospital; Helsingborgs Hospital; Göteborg University; Astellas Pharma Europe Ltd.; Norrlands University Hospital
Condition
COVID-19
Intervention
Enzalutamide Pill
Why stopped
By sponsor, based on DSMB recommendations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-02